chrisvoncsefalvay/vaers-outcomes huggingface dataset:
achiness; chills; fever; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (achiness), CHILLS (chills), PYREXIA (fever) and NAUSEA (Nausea) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced PAIN (achiness), CHILLS (chills), PYREXIA (fever) and NAUSEA (Nausea). At the time of the report, PAIN (achiness), CHILLS (chills), PYREXIA (fever) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Post vaccination, vitals at 1:50pm Pulse 81 BP 149 Resp 20.  Chief complaint of headache and dizziness.  Patient states he feels weird and would like to go to the hospital. Patient disposition by medical center ambulance with no other symptoms present.
(R) upper arm induration and erythema 11 x 10 cm x 24hrs. Started 24hrs after getting shot. (-) fever or other sx.
Vaccine given 1/7/10 10:40 AM. Patient developed angioedema 1/7/10 10:48AM. EP: 0.3mg IM given 1/7/10 10:49AM. Angioedema resolves/breathing restored 10:59AM. Patient transported to ER via ambulance for clearance 11:05AM. Patient given DECADRON and discharged from ER to home.
SEVERE pain left arm, nerve root symptomatology, unable to use left arm for three days.  Initially unable to bear the weight of the arm without severe excruciating pain.  Nerve root pain down distribution from T1 to C6, radiating down left arm.  Severe pain lasted four days, then gradually decreased in intensity, and lasted a total of five weeks.  No relief with medication, ice, or other palliative measures.
four days later I got very tired, sore throat, swollen face, pain on the left side of neck and face (which is already chronic for me, but this was more acute), and nerve pain across my left cheek under the sinus, right side of my face drooping (bells palsy)
headache and head/face congestions within 12 hours (and still have three days later), blurred/wobbly vision (started two days after, continuous and still have)
No further AE details/ No PQC; HCP called to report a TE. 3 Administered doses. Dose was administered on 9/11/2023, excursion occurred on 9/7/2023.; This spontaneous report has been received from a health care professional and refers to a. patient of unknown age and gender  The patient's pertinent medical history , other drug reactions or allergies, concurrent conditions and concomitant therapies were not reported.  On 11-SEP-2023, the patient was vaccinated with 3 doses of a varicella virus vaccine live (oka/merck) (VARIVAX) injection that had suffered a temperature excursion (product storage error), (lot number W039293 has been determined to be valid for varicella virus vaccine live (oka/merck) (VARIVAX), with an expiration date established as 11-DEC-2024), administered for prophylaxis (strength, and anatomical site of administration were not provided). The temperature excursion had a timeframe of 30 minutes at a temperature of -14 degrees Celsius (C) and -10 C up to 8 C). No adverse events were reported.
perfuse sweating; fever of 103; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (perfuse sweating), PYREXIA (fever of 103) and FATIGUE (fatigue) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (perfuse sweating), PYREXIA (fever of 103) and FATIGUE (fatigue). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, HYPERHIDROSIS (perfuse sweating), PYREXIA (fever of 103) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported.
Breakthrough case after 4 vaccines Pfizer 2/2/21 Lot# EL9265;  Pfizer 2/23/21 Lot# EN6200;  Pfizer 10/25/21 Lot# FF8841;  Pfizer 5/2/22 Lot# FM9992
Sinus drainage and persistent dry cough, lasting for 3-4 weeks; prescribed Rx cough syrup.   Tested positive for COVID, began Doctor prescribed Paxlovid 12/02/2022. No chest congestion.  No fever.  Normal BP and temperature. Continuing fatigue, lasting 3 weeks. Isolated for 2 weeks.
Pain in left arm (where injection was given) radiating down to elbow. Becomes severe when moving arm up or over to the right side. Severe at night. Became worse the next day and continues with no relief. No relief from anti-inflammatories (ibuprofen, Mobic).
18 mo infant with cold x 2-3 days, temp 99.2 deg, playing-came in for routine check up and got DTaP. Tonsils were red-strep screen neg, eating well, went home, playing, got in mom's lap and had tonic clonic sz with 105.3 deg temp lasting 2-5 minutes. Alert on arrival to ER-received Rocephin in hospital, neck supple, asymptoms-lots of upper airway congestion and clear rhinorrhea. Never had spine tap.
No additional adverse events reported; improperly stored vaccines were potentially administered to unknown patients; This spontaneous report has been received from a licensed practical nurse, referring to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.   On 22-DEC-2021, the patient was vaccinated with improperly stored measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (recombinant Human albumin (rHA)) (M-M-R II) (lot # T033815 with expiration date: 05-OCT-2022, route, strength and dose were unknown) for prophylaxis (Product storage error). No additional adverse events reported.  Administered dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (recombinant Human albumin (rHA)) (M-M-R II) experienced the temperature excursion with 49.6 Fahrenheit degrees (F) for 35 hours 9 minutes. The previous temperature excursions were reported as 32.9F for 53 hours 16 minutes; 49.1F for 5 hours 9 minutes; 56.3F for 14 hours 7 minutes.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2202USA003592: US-009507513-2203USA003310: US-009507513-2203USA003311: US-009507513-2203USA003312: US-009507513-2203USA003313: US-009507513-2203USA003314: US-009507513-2203USA003315: US-009507513-2203USA003316: US-009507513-2203USA003317: US-009507513-2203USA003318: US-009507513-2203USA003319: US-009507513-2203USA003320: US-009507513-2203USA003321: US-009507513-2203USA003322: US-009507513-2203USA003323: US-009507513-2203USA003324: US-009507513-2203USA003325: US-009507513-2203USA003327: US-009507513-2203USA003328: US-009507513-2203USA003329: US-009507513-2203USA003330: US-009507513-2203USA003331: US-009507513-2203USA003332: US-009507513-2203USA003333: US-009507513-2203USA003334: US-009507513-2203USA003335:
hard feeling; circular lump the size an orange; hot to touch; it was red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (circular lump the size an orange), VACCINATION SITE WARMTH (hot to touch), VACCINATION SITE ERYTHEMA (it was red) and VACCINATION SITE INDURATION (hard feeling) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025LZ(or 2)0A) for COVID-19 vaccination.     The patient's past medical history included Cholesterol. Concurrent medical conditions included Milk allergy, Drug allergy, Drug allergy, Drug allergy, Drug allergy, Drug allergy, Drug allergy, Drug allergy, Drug allergy, Drug allergy, Drug allergy, Drug allergy and Drug allergy. Concomitant products included AMOXICILLIN TRIHYDRATE, CLARITHROMYCIN, ESOMEPRAZOLE MAGNESIUM (NEXIUM 1-2-3) and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jan-2021, the patient experienced VACCINATION SITE MASS (circular lump the size an orange), VACCINATION SITE WARMTH (hot to touch) and VACCINATION SITE ERYTHEMA (it was red). On 16-Jan-2021, the patient experienced VACCINATION SITE INDURATION (hard feeling). At the time of the report, VACCINATION SITE MASS (circular lump the size an orange), VACCINATION SITE WARMTH (hot to touch), VACCINATION SITE ERYTHEMA (it was red) and VACCINATION SITE INDURATION (hard feeling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  Concomitant medication also included allergy shot.
L leg swollen, red, painful gave Benedryl and Motrin x 3days. Also warm compresses to thigh
Vaccine recommended by MD. Pt reported no KNDA, no health conditions at the time of getting the shot. Pt saw "small dots around one side of her body, mainly breast area, it itches and she feels slight pain in the rib area. Rash is not open, she did not report this to her MD. I spoke with her on 8/17/14 and referred her to MD. Filled out this form and faxed. Pt not sure rash is due to shot , therefore, I referred her to MD.
Red,raised welts from head to toe. Itchy at times. Parents describe it as "hives".
Sub dermal test site became red inflamed burning itching, ice placed to area (1/2) dose test site
I am not sure if this is a reaction to the vaccine or not, but thought perhaps it might be useful to you to report it in case you might be receiving other reports of the same.    I developed two small dark red spots, one on each thigh just above the knees.  I don't remember the exact date they appeared but it was definitely after receiving my second vaccine.  They did not itch or hurt and didn't go away after 3 months, so I went to the dermatologist to try and determine what they were.   The PA took a biopsy and the report came back they are granuloma annulare.   I researched online about them, and found out one cause could possibly be a correlation to vaccinations.  Any of the other possible cases do not pertain to me.    After my research, I realized they appeared after getting my second Covid vaccine and speculate that they could  be related, especially since I've never had it,  and further, I also had the Covid rash on my arm after the first dose.
20 mins after I gave  him the vaccine, the patient blood pressure  went high 142/90 and his pulse was 126. The patient was alert and oriented. He was stable. I kept checking his blood pressure every 15 -20 min until the  pulse came down to 100. He was ok ,and went home with his wife. I called him this morning 05/13 and his blood pressure is now 120/80.
Felt immediate fatigue, weakness and shaky.  Within 15 minutes, feeling better.  No other issues reported.
Seizure 3 hours post administration of HPV 1st seizure - no other risk factors.  7/9/09 Hospital ED records received DOS 6/15/09. Assessment: New onset seizure, possibly secondary to tramadol use. Relative reports that patient while on bus had an onset of shaking of upper extremities, right extremities in a 'frozen' kind of extension. Eyes rolled back, some saliva, lips turned blue. Patient woke up and was confused. Exam reveals only slight right lateral nystagmus. Medical Center and neurology referral and MRI suggested.
loss of taste after taking the second shot of the vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (loss of taste after taking the second shot of the vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced AGEUSIA (loss of taste after taking the second shot of the vaccine). At the time of the report, AGEUSIA (loss of taste after taking the second shot of the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact
Patient was given booster dose of Pfizer vaccine while only 15 years old, no adverse reaction seen to date, will continue to monitor patient for adverse reactions. Patient's mother was called and informed of the error in administration and told to monitor son for any adverse reactions.
has not been feeling that great; terrible pain under right breast; Caller states she read that there could be inflammation of the lining of the heart, wondering if this could be that.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 76 year-old female patient received bnt162b2 (BNT162B2), administration date 12Nov2021 (Batch/Lot number: unknown) at the age of 76 years as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MYOCARDITIS (medically significant) with onset Nov2021, outcome "unknown", described as "Caller states she read that there could be inflammation of the lining of the heart, wondering if this could be that."; BREAST PAIN (non-serious) with onset 15Nov2021, outcome "not recovered", described as "terrible pain under right breast"; MALAISE (non-serious), outcome "unknown", described as "has not been feeling that great". The lot number for bnt162b2 was not provided and will be requested during follow up.
I started MenstruaL spotting a day after the shot. It was so light at first I thought I was mistaken as it's definitely not normal and it has gotten worse since. I got the shot Wednesday afternoon and called my primary care office when I got off work late Friday afternoon. Waiting for Monday to go into the office.
Extreme fatigue; body aches; headache; fever; chills; sinus pressure; joint pain; This is a spontaneous report from a non-contactable nurse (patient). A 38-years-old female patient received bnt162b2 (PFIZER-BIOTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number: unknown), via an unspecified route of administration, administered in arm right on 02Feb2021 at 13:30 (at the age of 38-years-old) as second dose, single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously took first dose of bnt162b2 (PFIZER-BIOTECH COVID-19 VACCINE), administered in right arm on 12Jan2021 at 13:30 for COVID-19 immunization. The patient did not had COVID prior to vaccination and was not tested for COVID post vaccination. On 02Feb2021 at 19:00, the patient experienced extreme fatigue, body aches, headache, fever, chills, sinus pressure and joint pain. The patient did not receive treatment for the events. The outcome of all the events was not resolved.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
Patient was found down at her assisted living facility. Admitted to hospital with altered mental status, severe sepsis secondary to cholecystitis, atrial fibrillation, new diagnosis of cirrhosis with ascites (unknown etiology), streptococcal bacteremia from infective endocarditis. Hospitalization then complicated by bowel perforation, patient transitioned to comfort care and passed away.
On 01/04/2021 I was with friends and the next day had a friend who tested positive for Covid-19. 2 days later I developed a fever. It persisted. I became fatigued. On Saturday I tested for Covid-19 and it came back negative. The following Tuesday I contacted my doctor. On Wednesday I had another Covid-19 test, which was negative. The fever persisted. On 01/13 I went to see my doctor and she said I must have had Covid-19 even though I tested negative twice. She had a chest x-ray completed and it was normal. The fever and fatigue persisted. Then she had me come in and have blood test done and everything was normal. Then the fever went away. I had another Covid-19 test and was negative. I flew out of the country and then had another Covid-19 test coming back to the country and it was negative again. I usually do not have fevers.
Tingling and numbness in both hands and both feet, weak muscles in upper back, lower back, legs and arms poor bladder and bowel control, limited numbness in legs and lower torso up to but not including the chest  TREATMENT 5 days of IV of immunogobulins each day 30ml except for days 4 which was 24ml and day 5 which was 26ml because enough was not found. Information from Medical records includes back pain as symptoms. msv  Discharge summary states reflexes decreased, ataxia, GBS, weak. msv 3/31/2010 Follow up: Sensory loss in legs and feet along with recurrent pain in hand and forearms developing arthritis in joints.
She developed a "normally" sore left arm after receiving the vaccination, but this progressed to an extremely painful left arm, approximately one week after receiving the vaccination. It was severe enough that she could barely lift the arm for 3 weeks due to pain and could not exercise. There was no erythema or swelling. The patient clearly remembers that the vaccine was not given high near the shoulder. She also developed rib pain that extended around the edge of the left rib cage. In mid Apr '12, approximately 4 weeks after vaccination, she developed weakness and "muscle atrophy" in the entire body and lost 20 lbs in the next 4 months. She continued with exquisite left arm pain especially on palpation. She also had debilitating fatigue necessitating frequent rest periods. She still was unable to use her left arm fully, and also states she "bruised" a lot. She sought medical evaluation and was diagnosed with anxiety and was prescribed sertraline. The arm pain, fatigue and energy level gradually began to improve about 8 months later, but the pain in the left rib cage has never resolved.
Patient with history of 3 COVID Vaccines who admitted with COVID detected PCR.  Provider d/c note:  "86 year-old male with a history of chronic indwelling foley catheter, dementia/depression/anxiety, CKD stage IIIB, chronic normocytic anemia, hypothyroidism, recent urinary tract infection treated with bactrim presented to hospital due to generalized weakness. Found to be COVID-19 positive incidentally and diagnosed with acute cystitis without hematuria from pseudomonas. Was treated with 2 days of rocephin followed by 7 days of cefepime. He was alsop given supportive care for mildly symptomatic COVID infection with Tessalon Perles and nasal saline spray. While hospitalized, he developed R podagra. He received a steroid injection into the joint to relieve inflammation from synovitis, with the podagra subsequently resolving. He was evaluated by physical therapy and occupational therapy who assessed him to be appropriate for discharge to post acute rehab. Due to COVID precautions his discharge was delayed and he was discharged on 12/24/2022"
Vaccine Induced Thrombocytopenia, -  purpura developed initially and incidental lab finding was Total Platelet Count of 6000 in early November.
Whole body aches; Fever; This is a spontaneous report from a contactable healthcare professional, the patient. A 47-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW161) via an unspecified route of administration in the left arm on 17Apr2021 at 16:15 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 18Apr2021 at 06:30, the patient experienced whole body aches and fever. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events whole body aches and fever was recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Developed chest pain.; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 37-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: Ep6955, Expiry date was not reported) via an unspecified route of administration in arm left (at the age of 37-year-old) on 07Apr2021 10:30 as single dose for COVID-19 immunization. The patient medical history was not reported, no known allergy. Concomitant medication(s) included terbinafine (LAMISIL) taken for an unspecified indication, start and stop date were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: En6208, Expiry date was not reported) via an unspecified route of administration at arm left (at the age of 37-year-old) on 17Mar2021 10:30 (Lot Number: En6208) as single dose for COVID-19 immunisation. The patient did not have COVID prior vaccination. The patient had not tested COVID post vaccination. On 27Apr2021 the patient experienced developed chest pain. Patient received treatment for the event in the form of pills. The adverse event resulted in consultation in Doctor or other healthcare professional office/clinic visit. The outcome for the event was not recovered.  No follow-up attempts are possible. No further information is expected.  Follow-up attempts are completed. No further information is expected.